Back
ESC Professional Premium Access

Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients

Session: Chronic heart failure - Amyloidosis
Topic: Pharmacotherapy
Speaker: Doctor T. Maurer (Cambridge, Ma, US)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Tristan Maurer

Cambridge, Ma (United States of America)
0 follower

6 more presentations in this session

Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study

Speaker: Doctor N. Verheyen (Graz, AT)

Access
Abstract
Slides
Thumbnail

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Speaker: Assistant Professor A. Briasoulis (Iowa City, US)

Access
Abstract
Slides
Thumbnail

Hypertension is associated with more advanced heart failure in african americans with suspected cardiac amyloidosis

Speaker: Doctor S. Manjunath (Saint Louis, US)

Access
Abstract
Slides
Thumbnail

Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy

Speaker: Professor R. Witteles (Palo Alto, US)

Access
Abstract
Slides
Thumbnail

Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy

Speaker: Doctor S. Takashio (Kumamoto, JP)

Access
Abstract
Slides
Thumbnail

Access the full session

Chronic heart failure - Amyloidosis

Speakers: Doctor T. Maurer, Doctor N. Verheyen, Assistant Professor A. Briasoulis, Doctor S. Manjunath, Professor R. Witteles...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb